Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Ovarian Serous Adenocarcinoma	Regeneron Pharmaceuticals	P1/2	CCC (48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Metastatic Malignant Neoplasm	OncoResponse, Inc.	P1/2	CCC (48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Endometrial Cancer	Regeneron Pharmaceuticals	P1/2	CCC (48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Urothelial Carcinoma	Palleon Pharmaceuticals, Inc.	P1/2	CCC (48)
immunoglobulin H-gamma1_L-kappa, anti-[Homo sapiens CD47 (CD47 molecule, integrin associated protein, IAP, MER6, OA3) and anti-[Homo sapiens DLL3 (delta-like ligand 3, delta like canonical Notch ligand 3)], bispecific; Neuroendocrine Carcinoma	Phanes Therapeutics	P1/2	CCC (48)
Inavolisib Estrogen-Receptor Positive Breast Cancer	Hoffmann-La Roche	P1/2	CCC (48)
Infliximab Vasculitis	University of California, San Francisco	P1/2	CCC (48)
Inobrodib Myelodysplastic Syndrome	CellCentric Ltd.	P1/2	CCC (48)
Inositol Anxiety Disorder	Ronald M. Glick, MD	P1/2	CCC (48)
Interleukin-15 Lung Carcinoma	Essen Biotech	P1/2	CCC (48)
Interleukin 18 (Recombinant Human Mutein Clone St-067) Follicular Lymphoma	Fred Hutchinson Cancer Center	P1/2	CCC (48)
Interleukin 18 (Recombinant Human Mutein Clone St-067) High Grade B-Cell Lymphoma	Fred Hutchinson Cancer Center	P1/2	CCC (48)
Interleukin 18 (Recombinant Human Mutein Clone St-067) Indolent B-Cell Non-Hodgkin Lymphoma	Fred Hutchinson Cancer Center	P1/2	CCC (48)
Interleukin 18 (Recombinant Human Mutein Clone St-067) Head And Neck Squamous Cell Carcinoma	Simcha IL-18, Inc.	P1/2	CCC (48)
Intrathalamic Avb-101 Frontotemporal Dementia	AviadoBio Ltd	P1/2	CCC (48)
Intratumoral Mmr Pancreatic Neoplasm	University of Arkansas	P1/2	CCC (48)
Intratumoral Mmr Malignant Pancreatic Neoplasm	University of Arkansas	P1/2	CCC (48)
Inv-8989 Biliary Tract Cancer	Shenzhen Ionova Life Sciences Co., Ltd.	P1/2	CCC (48)
Inv-8989 Pancreatic Adenocarcinoma	Shenzhen Ionova Life Sciences Co., Ltd.	P1/2	CCC (48)
Inv-9956 Castration-Resistant Prostate Carcinoma	Shenzhen Ionova Life Sciences Co., Ltd.	P1/2	CCC (48)
ion283 Lafora Disease	Berge Minassian	P1/2	CCC (48)
Iov-3001 Ocular Melanoma	Iovance Biotherapeutics, Inc.	P1/2	CCC (48)
Iov-3001 Melanoma	Iovance Biotherapeutics, Inc.	P1/2	CCC (48)
Iov-4001 Non-Small Cell Lung Carcinoma	Iovance Biotherapeutics, Inc.	P1/2	CCC (48)
Ipilimumab Pleural Mesothelioma	TCR2 Therapeutics	P1/2	CCC (48)

Showing 1376 to 1400 of 6,308 assets

PreviousPage 56 of 253Next